University of Ioannina
Εμπειρική αποτίμηση και συστηματική ανασκόπηση προγνωστικών δεικτών και προγνωστικών μοντέλων για χρόνια νοσήματα
Abstract
dc:descriptionPrognosis is defined as the likelihood of displaying a condition at a specific time period, based on specific characteristics, named prognostic factors. A prognostic model is a mathematical function that relates multiple prognostic factors to the probability (risk) of a particular outcome. Prognosis research and prognostic models for chronic diseases, such as cardiovascular disease and cancer, is crucial for patient counseling and clinical decision making. Our first aim was to map the expanded used of the Framingham Risk Score (FRS), one of the most important prognostic models in cardiovascular disease, in the medical literature. We identified all citations to the original Wilson et al.1998 paper where FRS was originally described. We identified 375 eligible papers corresponding to 471 analyses using the FRS in cohort, case-control or cross-sectional settings. The studied population was different (from healthy) in 25% and 42% of the cohort and cross-sectional analyses, respectively. The studied outcome was different (from coronary heart disease) in 56% of the cohort analyses and in 63% of the case-control studies. Overall, only 33% of the cohort analyses examined the same outcome and population as FRS was originally developed for. In conclusion, a large number of studies use FRS in different settings than originally developed for, for which its performance is unknown and non-validated. Before using prognostic models in different settings than originally developed recalibration/update and external validation is required. Our second objective was to provide a systematic review of secondary prevention models in patients with already established cardiovascular disease. Using MEDLINE and EMBASE databases between January 2004 and June 2013, we identified 79 eligible articles. Most new models were developed in USA and Europe, on patients with coronary artery disease and a mean age of 65 years. The majority of models used Cox or logistic regression, 5 to 7 predictors, and C-statistic and the Hosmer-Lemeshow test for assessing model performance. Framingham Risk Score (FRS), CHADS2, SYNTAX and GRACE were the models more frequently externally validated. Finally, FRS was the model mostly incremented, and CRP and NT-proBNP were the most commonly examined risk factors. In conclusion, the majority of models used in secondary prevention are newly derived models without proper external validation. Finally, we conducted a meta-analysis to assess the association between hypertension (a prognostic factor) and site-specific cancer (a chronic disease). After searching PubMed until November 2017, we identified a total of 148 eligible publications. Considering only evidence from 85 prospective studies, we conducted 30 meta-analyses of hypertension and 16 different cancers. Positive associations were observed between hypertension and kidney, colorectal and breast cancer. Positive associations between hypertension and risk of oesophageal, liver, and endometrial cancers were also observed, but the majority of studies did not perform comprehensive multivariable adjustments.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2020
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Seretis, Aristeidis
- Σερέτης, Αριστείδης
Subjects
dc:subject × 26- Προγνωστικοί παράγοντες
- Παράγοντες κινδύνου
- Προγνωστικά μοντέλα
- Πρόγνωση
- Χρόνιες νόσοι
- Καρδιαγγειακή νόσος
- Καρκίνος
- Υπέρταση
- Μετα-ανάλυση
- Συστηματική ανασκόπηση
- Prognostic factors
- Risk factors
- Prognostic models
- Prognosis
- Chronic diseases
- Cardiovascular disease
- Cancer
- Hypertension
- Meta-analysis
- Systematic review
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Επιστήμες Υγείας
- Medical and Health Sciences
- Basic Medicine
- Health Sciences
Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/48892